Caricamento...
Rituximab in refractory sarcoidosis: a single centre experience
Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune suppressants drugs are currently used in the disease management. However, refractory disease...
Salvato in:
| Pubblicato in: | Clin Mol Allergy |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4556310/ https://ncbi.nlm.nih.gov/pubmed/26330764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-015-0025-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|